Trial Profile
Retrospective trial to study the efficacy of omalizumab in patients with elevated baseline IgE
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Mar 2016
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- 15 Mar 2016 New trial record
- 07 Mar 2016 Results presented at the 2016 Annual Meeting of the American Academy of Allergy, Asthma and Immunology